We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Generic Drugs Market Size Share Forecast 2024




 

In the world economic growth, the Generic Drugs industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Generic Drugs market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Generic Drugs market size will be further expanded, we expect that by 2024, The market size of the Generic Drugs will reach XXX million $.

Overview

A generic drug is basically a generic drug, which contains the same active ingredient as a patented drug that was first protected by proprietary patents. Generic drugs are typically allowed for commercial sale after the exclusive patents on these drugs expire. This is generally within three years of the date of original manufacture. The original patent granted to the innovator for the specific chemical involved in the invention of the drug has to be honored throughout the term of the patent. If this happens then any generic drug containing the same ingredient as the one patented can legally be sold. The global generic drugs market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global generic drugs market is expected to witness significant growth during the forecast period, owing to increasing geriatric population.

Market Drivers

Increasing prevalence of chronic diseases such as hypertension, cancer, and cardiovascular diseases (CVD) is expected to drive growth of the global generic drugs market during the forecast period. According to the World Health Organization (WHO), in 2018, around 9.6 million died due to cancer with over 300,000 new cases of cancer being diagnosed each year among children aged 0-19 years across the globe. According to the World Health Organization (WHO), around 17.9 million people die each year from cardiovascular disease worldwide. Generic drugs offer various advantages including low cost, similar effectiveness that of brand-name alternatives, and overall reduction in healthcare cost. Hence, such factors are expected to drive growth of the global generic drugs market during the forecast period. Moreover, increasing geriatric population is expected to propel the global generic drugs market growth over the forecast period.

Market Restraints

Stringent government regulations are expected to hinder the global generic drugs market growth over the forecast period.

Regional Insights

Among regions, North America is expected to witness significant growth in the global generic drugs market during the forecast period. This is owing to the presence of key companies and the launch of new products in the region. Moreover, Asia Pacific is expected to register a robust growth rate, owing to rising awareness among people related to any disorder in the region.

Competitive Section

Key players operating in the global generic drugs market are Teva, Novartis, Sun Pharmaceutical, Mylan, Sanofi, Pfizer, and Sun Pharmaceutical.

For instance, in March 2021, Biocon partnered with Libbs Farmaceutica to launch generic drugs in Brazil. 

This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI

Section 1: Definition

Section (2 3): Manufacturer Detail
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma

Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)

Section (5 6 7): 
Product Type Segmentation
Simple Generic Drugs
Super Generic Drugs
Biosimilars

Industry Segmentation
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology

Channel (Direct Sales, Distributor) Segmentation

Section 8: Trend (2019-2024)

Section 9: Product Type Detail

Section 10: Downstream Consumer

Section 11: Cost Structure

Section 12: Conclusion

Table of Contents
Section 1 Generic Drugs Product Definition

Section 2 Global Generic Drugs Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Generic Drugs Shipments
2.2 Global Manufacturer Generic Drugs Business Revenue
2.3 Global Generic Drugs Market Overview

Section 3 Manufacturer Generic Drugs Business Introduction
3.1 Teva Generic Drugs Business Introduction
3.1.1 Teva Generic Drugs Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Teva Generic Drugs Business Distribution by Region
3.1.3 Teva Interview Record
3.1.4 Teva Generic Drugs Business Profile
3.1.5 Teva Generic Drugs Product Specification

3.2 Novartis - Sandoz Generic Drugs Business Introduction
3.2.1 Novartis - Sandoz Generic Drugs Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Novartis - Sandoz Generic Drugs Business Distribution by Region
3.2.3 Interview Record
3.2.4 Novartis - Sandoz Generic Drugs Business Overview
3.2.5 Novartis - Sandoz Generic Drugs Product Specification

3.3 Mylan Generic Drugs Business Introduction
3.3.1 Mylan Generic Drugs Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Mylan Generic Drugs Business Distribution by Region
3.3.3 Interview Record
3.3.4 Mylan Generic Drugs Business Overview
3.3.5 Mylan Generic Drugs Product Specification

3.4 Sun Pharmaceutical Generic Drugs Business Introduction
3.5 Aspen Generic Drugs Business Introduction
3.6 Fresenius Kabi Generic Drugs Business Introduction


Section 4 Global Generic Drugs Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Generic Drugs Market Size and Price Analysis 2014-2019
4.1.2 Canada Generic Drugs Market Size and Price Analysis 2014-2019
4.2 South America Country
4.2.1 South America Generic Drugs Market Size and Price Analysis 2014-2019
4.3 Asia Country
4.3.1 China Generic Drugs Market Size and Price Analysis 2014-2019
4.3.2 Japan Generic Drugs Market Size and Price Analysis 2014-2019
4.3.3 India Generic Drugs Market Size and Price Analysis 2014-2019
4.3.4 Korea Generic Drugs Market Size and Price Analysis 2014-2019
4.4 Europe Country
4.4.1 Germany Generic Drugs Market Size and Price Analysis 2014-2019
4.4.2 UK Generic Drugs Market Size and Price Analysis 2014-2019
4.4.3 France Generic Drugs Market Size and Price Analysis 2014-2019
4.4.4 Italy Generic Drugs Market Size and Price Analysis 2014-2019
4.4.5 Europe Generic Drugs Market Size and Price Analysis 2014-2019
4.5 Other Country and Region
4.5.1 Middle East Generic Drugs Market Size and Price Analysis 2014-2019
4.5.2 Africa Generic Drugs Market Size and Price Analysis 2014-2019
4.5.3 GCC Generic Drugs Market Size and Price Analysis 2014-2019
4.6 Global Generic Drugs Market Segmentation (Region Level) Analysis 2014-2019
4.7 Global Generic Drugs Market Segmentation (Region Level) Analysis

Section 5 Global Generic Drugs Market Segmentation (Product Type Level)
5.1 Global Generic Drugs Market Segmentation (Product Type Level) Market Size 2014-2019
5.2 Different Generic Drugs Product Type Price 2014-2019
5.3 Global Generic Drugs Market Segmentation (Product Type Level) Analysis

Section 6 Global Generic Drugs Market Segmentation (Industry Level)
6.1 Global Generic Drugs Market Segmentation (Industry Level) Market Size 2014-2019
6.2 Different Industry Price 2014-2019
6.3 Global Generic Drugs Market Segmentation (Industry Level) Analysis

Section 7 Global Generic Drugs Market Segmentation (Channel Level)
7.1 Global Generic Drugs Market Segmentation (Channel Level) Sales Volume and Share 2014-2019
7.2 Global Generic Drugs Market Segmentation (Channel Level) Analysis

Section 8 Generic Drugs Market Forecast 2019-2024
8.1 Generic Drugs Segmentation Market Forecast (Region Level)
8.2 Generic Drugs Segmentation Market Forecast (Product Type Level)
8.3 Generic Drugs Segmentation Market Forecast (Industry Level)
8.4 Generic Drugs Segmentation Market Forecast (Channel Level)

Section 9 Generic Drugs Segmentation Product Type
9.1 Simple Generic Drugs Product Introduction
9.2 Super Generic Drugs Product Introduction
9.3 Biosimilars Product Introduction

Section 10 Generic Drugs Segmentation Industry
10.1 CNS Clients
10.2 Cardiovascular Clients
10.3 Genitourinary/Hormonal Drugs Clients
10.4 Respiratory Clients
10.5 Rheumatology Clients

Section 11 Generic Drugs Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview

Section 12 Conclusion

Chart and Figure
Figure Generic Drugs Product Picture from Teva
Chart 2014-2019 Global Manufacturer Generic Drugs Shipments (Units)
Chart 2014-2019 Global Manufacturer Generic Drugs Shipments Share
Chart 2014-2019 Global Manufacturer Generic Drugs Business Revenue (Million USD)
Chart 2014-2019 Global Manufacturer Generic Drugs Business Revenue Share
Chart Teva Generic Drugs Shipments, Price, Revenue and Gross profit 2014-2019
Chart Teva Generic Drugs Business Distribution
Chart Teva Interview Record (Partly)
Figure Teva Generic Drugs Product Picture
Chart Teva Generic Drugs Business Profile
Table Teva Generic Drugs Product Specification
Chart Novartis - Sandoz Generic Drugs Shipments, Price, Revenue and Gross profit 2014-2019
Chart Novartis - Sandoz Generic Drugs Business Distribution
Chart Novartis - Sandoz Interview Record (Partly)
Figure Novartis - Sandoz Generic Drugs Product Picture
Chart Novartis - Sandoz Generic Drugs Business Overview
Table Novartis - Sandoz Generic Drugs Product Specification
Chart Mylan Generic Drugs Shipments, Price, Revenue and Gross profit 2014-2019
Chart Mylan Generic Drugs Business Distribution
Chart Mylan Interview Record (Partly)
Figure Mylan Generic Drugs Product Picture
Chart Mylan Generic Drugs Business Overview
Table Mylan Generic Drugs Product Specification
3.4 Sun Pharmaceutical Generic Drugs Business Introduction

Chart United States Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart United States Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Canada Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Canada Generic Drugs Sales Price ($/Unit) 2014-2019
Chart South America Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart South America Generic Drugs Sales Price ($/Unit) 2014-2019
Chart China Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart China Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Japan Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Japan Generic Drugs Sales Price ($/Unit) 2014-2019
Chart India Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart India Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Korea Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Korea Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Germany Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Germany Generic Drugs Sales Price ($/Unit) 2014-2019
Chart UK Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart UK Generic Drugs Sales Price ($/Unit) 2014-2019
Chart France Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart France Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Italy Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Italy Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Europe Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Europe Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Middle East Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Middle East Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Africa Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Africa Generic Drugs Sales Price ($/Unit) 2014-2019
Chart GCC Generic Drugs Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart GCC Generic Drugs Sales Price ($/Unit) 2014-2019
Chart Global Generic Drugs Market Segmentation (Region Level) Sales Volume 2014-2019
Chart Global Generic Drugs Market Segmentation (Region Level) Market size 2014-2019
Chart Generic Drugs Market Segmentation (Product Type Level) Volume (Units) 2014-2019
Chart Generic Drugs Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019
Chart Different Generic Drugs Product Type Price ($/Unit) 2014-2019
Chart Generic Drugs Market Segmentation (Industry Level) Market Size (Volume) 2014-2019
Chart Generic Drugs Market Segmentation (Industry Level) Market Size (Share) 2014-2019
Chart Generic Drugs Market Segmentation (Industry Level) Market Size (Value) 2014-2019
Chart Global Generic Drugs Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019
Chart Global Generic Drugs Market Segmentation (Channel Level) Share 2014-2019
Chart Generic Drugs Segmentation Market Forecast (Region Level) 2019-2024
Chart Generic Drugs Segmentation Market Forecast (Product Type Level) 2019-2024
Chart Generic Drugs Segmentation Market Forecast (Industry Level) 2019-2024
Chart Generic Drugs Segmentation Market Forecast (Channel Level) 2019-2024
Chart Simple Generic Drugs Product Figure
Chart Simple Generic Drugs Product Advantage and Disadvantage Comparison
Chart Super Generic Drugs Product Figure
Chart Super Generic Drugs Product Advantage and Disadvantage Comparison
Chart Biosimilars Product Figure
Chart Biosimilars Product Advantage and Disadvantage Comparison
Chart CNS Clients
Chart Cardiovascular Clients
Chart Genitourinary/Hormonal Drugs Clients
Chart Respiratory Clients
Chart Rheumatology Clients

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.